Home

Pacira BioSciences, Inc. - Common Stock (PCRX)

26.17
-0.07 (-0.27%)

Pacira Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative non-opioid pain management solutions

The company is dedicated to improving patient outcomes by offering products that mitigate post-surgical pain while minimizing the reliance on traditional opioid medications. Pacira's lead product is designed for effective local anesthetic delivery, aiming to enhance recovery experiences for patients undergoing various surgical procedures. Through its commitment to research and development, Pacira seeks to advance medical practices in pain management and promote safer alternatives for both healthcare providers and patients.

SummaryNewsPress ReleasesChartHistoricalFAQ